Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?

Nuclear Medicine Communications

Volumn 30, Issue 1, 2009, Pages 48-53

  Koukouraki, Sophia ^a   Sanidas, Elias ^a   Askoxilakis, John ^a   Stathaki, Maria ^a   Charalambakis, Vassilis ^a   Daboudi, Maria ^a   Voutoufianaki, Ioanna ^a   Kafousi, Maria ^a   Stathopoulos, Eustathios ^a   Tsiftsis, Dimitris ^a   Karkavitsas, Nikolaos ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Axillary lymph node dissection; Breast cancer; Radioisotopic and dye techniques; Sentinel lymph node biopsy

Indexed keywords

DISULFINE BLUE; TECHNETIUM 99M;

ADULT; AGED; ARM EDEMA; ARTICLE; BREAST CANCER; CANCER STAGING; FALSE NEGATIVE RESULT; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE TRACING; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; SENTINEL LYMPH NODE BIOPSY; STAINING;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; COLORING AGENTS; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 57749194929     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283139302     Document Type: Article

References (21)

1. Tan YY, Fan YG, Lu Y, Hwang S, Ewing C, Esserman L, et al. Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients. Breast J 2005; 11:248-253.
2. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339:941-946.
3. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 1997; 349:1668-1669.
4. Zavagno G, De Salvo GL, Casara D, Del Bianco P, Rubello D, Meggiolaro F, et al. Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian region. BMC Cancer 2004; 4:2.
5. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39:456-466.
6. Schwartz GF, Guiliano AE, Veronesi U. Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA. Breast J 2002; 8:124-138.
7. Kern K. Breast lymphatic mapping using subareolar injections of blue dye and radiocolloid: illustrated technique. J Am Coll Surg 2001; 192:545-550.
8. Reintgen D, Giuliano R, Cox CE. Sentinel node biopsy in breast cancer: an overview. Breast J 2000; 6:299-305.
9. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399.
10. Krag D, Harlow S, Weaver D, Ashikaga T. Technique of sentinel node resection in melanoma and breast cancer: probe-guided surgery and lymphatic mapping. Eur J Surg Oncol 1998; 24:89-93.
11. Olson JA, Fey J, Winawer J, Borgen PI, Cody HS, Van Zee KJ, et al. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 2000; 191:593-599.
12. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999; 91:368-373.
13. Cox CE, Furman B, Dupont EL, Jakub JW, Stowell N, Clark J, et al. Novel techniques in sentinel lymph node mapping and localization of nonpalpable breast lesions: the Moffitt experience. Ann Surg Oncol 2004; 11 (Suppl 3):222-226.
14. Sanidas EE, Daskalakis M, Sbyrakis N, Tsiftsis DD. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy. Eur J Surg Oncol 2005; 31:357-363.
15. Sanidas EE, de Bree E, Tsiftsis DD. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg 2003; 185:202-210.
16. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-1822.
17. Kim HJ, Lee JS, Park EH, Choi SL, Lim WS, Chang MA, et al. Sentinel node biopsy in patients with multiple breast cancer. Breast Cancer Res Treat 2007; DOI 10.1007/s10549-007-9674-9.
18. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000; 18:2560-2566.
19. Cody HS, Fey J, Akhurst T, Fazzari M, Mazumdar M, Yeung H, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001; 8:13-19.
20. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349:546-553.
21. Sandrucci S, Casalegno PS, Percivale P, Mistrangelo M, Bombardieri E, Bertoglio S. Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures. Tumori 1999; 85:425-434.